Test Bank For Pharmacology Clear and Simple:
C C C C C C C
A Guide to Drug Classifications and Dosage Calculations,
C C C C C C C C
4th Edition by Cynthia J. Watkins
C C C C C C
Chapters 1 - 21
C C C C
,
,ChapterC1.CHistoryCofC Pharmacology
PharmacologyCClearCandCSimple-
CACGuideCtoCDrugCClassificationsCandCDosageCCalculationsC4thC
EditionCWatkinsCTestCBank
1.
ACnurseC workingC inCradiologyCadministersC iodineC toCaC patientC whoCisC havingC aCcompu
tedCtomographyC(CT)C scan.C TheC nurseC workingConC theC oncologyCunitCadministersCchemo
therapyCtoC patientsC whoC haveC cancer.C AtC theC PublicC HealthCDepartment,C aC nurseCadmi
nistersC aC measles-mumps-rubellaC (MMR)C vaccineCtoCaC14-month-
oldCchildCasCaCroutineCimmunization.CWhichCbranchCofCpharmacologyCbestCdescribesCth
eCactionsCofCallCthreeCnurses?
A) Pharmacoeconomics
B) Pharmacotherapeutics
C) Pharmacodynamics
D) Pharmacokinetics
ANSWER: B
Feedback:
PharmacologyCisCtheC studyCofCtheC biologicCeffectsCofCchemicals.C NursesCareCinvolvedCwi
thC clinicalC pharmacologyCorC pharmacotherapeutics,C whichC isCaCbranchCofCpharmacolog
yCthatC dealsCwithC theC usesCofCdrugsCtoCtreat,C prevent,CandCdiagnoseC disease.CTheC radiol
ogyCnurseC isCadministeringCaC drugCtoChelpCdiagnoseC aC disease.C TheC oncologyCnurseC isCa
dministeringC aC drugCtoC helpC treatCaC disease.C PharmacoeconomicsC includesC anyCcostsC in
volvedC inC drugC therapy.CPharmacodynamicsCinvolvesChowCaCdrugCaffectsCtheCbodyCandC
pharmacokineticsCisChowCtheCbodyCactsConCtheCbody.
2.
ACphysicianChasCorderedCintramuscularC(IM)CinjectionsCofCmorphine,CaCnar
cotic,CeveryC4ChoursCasCneededCforCpainCinCaCmotorCvehicleCaccidentCvictim.C
TheC nurseC isCawareC thisCdrugChasCaC highCabuseC potential.CUnderC whatCcateg
oryCwouldCmorphineCbeCclassified?
A) ScheduleCI
B) ScheduleCII
C) ScheduleCIII
D) ScheduleCIV
ANSWER: B
, Feedback:
NarcoticsCwithCaChighCabuseCpotentialCareCclassifiedCasCScheduleCIICdrugsCbeca
useCofCsevereC dependenceCliability.C ScheduleC ICdrugsChaveChighC abuseCpotent
ialC andC noCacceptedC medicalC use.C ScheduleC IIIC drugsC haveC aC lesserCabuseC pot
entialC thanC IICandC anCacceptedC medicalC use.C ScheduleC IVC drugsChaveClowCabus
eCpotentialCandClimitedCdependenceCliability.
3.
WhenC involvedC inC phaseC IIIC drugC evaluationC studies,C whatC responsibiliti
esCwouldCtheCnurseChave?
A) WorkingCwithC animalsC whoC areC givenC experimentalC drugs
B) ChoosingC appropriateC patientsC toCbeC involvedC inC theC drugCstudy
C) MonitoringC andC observingCpatientsC closelyCforC adverseC effects
D) ConductingC researchC toC determineC effectivenessC ofC theC drug
ANSWER: C
Feedback:
PhaseC IIICstudiesCinvolveC useCofCaC drugCinC aCvastC clinicalC populationCinCwhichCp
atientsCareC askedC toC recordC anyCsymptomsC theyCexperienceC whileC takingC theC
drugs.CNursesCmayCbeCresponsibleCforChelpingCcollectCandCanalyzeCtheCinform
ationC toC beCsharedCwithCtheCFoodC andC DrugCAdministrationC (FDA)C butCwouldC
notC conductC researchC independentlyCbecauseC nursesC doC notC prescribeCmedi
cations.C UseC ofCanimalsC inCdrugCtestingCisC doneCinCtheC preclinicalC trials.CSelect
C patientsC whoC areC involvedC inC phaseC IIC studiesC toC participateC inC studiesCwher
eCtheC participantsC haveCtheC diseaseC theCdrugCisCintendedCtoCtreat.C TheseCpati
entsCareCmonitoredC closelyCforCdrugCactionC andC adverseC effects.C PhaseC ICstud
iesCinvolveChealthyChumanCvolunteersCwhoCareCusuallyCpaidCforC theirCparticip
ation.CNursesCmayCobserveCforCadverseCeffectsCandCtoxicity.
4.
WhatC conceptC isCconsideredC whenC genericC drugsC areC substitutedC forC b
randCnameCdrugs?
A) Bioavailability
B) CriticalC concentration
C) Distribution
D) Half-life
ANSWER: A
Feedback:
C C C C C C C
A Guide to Drug Classifications and Dosage Calculations,
C C C C C C C C
4th Edition by Cynthia J. Watkins
C C C C C C
Chapters 1 - 21
C C C C
,
,ChapterC1.CHistoryCofC Pharmacology
PharmacologyCClearCandCSimple-
CACGuideCtoCDrugCClassificationsCandCDosageCCalculationsC4thC
EditionCWatkinsCTestCBank
1.
ACnurseC workingC inCradiologyCadministersC iodineC toCaC patientC whoCisC havingC aCcompu
tedCtomographyC(CT)C scan.C TheC nurseC workingConC theC oncologyCunitCadministersCchemo
therapyCtoC patientsC whoC haveC cancer.C AtC theC PublicC HealthCDepartment,C aC nurseCadmi
nistersC aC measles-mumps-rubellaC (MMR)C vaccineCtoCaC14-month-
oldCchildCasCaCroutineCimmunization.CWhichCbranchCofCpharmacologyCbestCdescribesCth
eCactionsCofCallCthreeCnurses?
A) Pharmacoeconomics
B) Pharmacotherapeutics
C) Pharmacodynamics
D) Pharmacokinetics
ANSWER: B
Feedback:
PharmacologyCisCtheC studyCofCtheC biologicCeffectsCofCchemicals.C NursesCareCinvolvedCwi
thC clinicalC pharmacologyCorC pharmacotherapeutics,C whichC isCaCbranchCofCpharmacolog
yCthatC dealsCwithC theC usesCofCdrugsCtoCtreat,C prevent,CandCdiagnoseC disease.CTheC radiol
ogyCnurseC isCadministeringCaC drugCtoChelpCdiagnoseC aC disease.C TheC oncologyCnurseC isCa
dministeringC aC drugCtoC helpC treatCaC disease.C PharmacoeconomicsC includesC anyCcostsC in
volvedC inC drugC therapy.CPharmacodynamicsCinvolvesChowCaCdrugCaffectsCtheCbodyCandC
pharmacokineticsCisChowCtheCbodyCactsConCtheCbody.
2.
ACphysicianChasCorderedCintramuscularC(IM)CinjectionsCofCmorphine,CaCnar
cotic,CeveryC4ChoursCasCneededCforCpainCinCaCmotorCvehicleCaccidentCvictim.C
TheC nurseC isCawareC thisCdrugChasCaC highCabuseC potential.CUnderC whatCcateg
oryCwouldCmorphineCbeCclassified?
A) ScheduleCI
B) ScheduleCII
C) ScheduleCIII
D) ScheduleCIV
ANSWER: B
, Feedback:
NarcoticsCwithCaChighCabuseCpotentialCareCclassifiedCasCScheduleCIICdrugsCbeca
useCofCsevereC dependenceCliability.C ScheduleC ICdrugsChaveChighC abuseCpotent
ialC andC noCacceptedC medicalC use.C ScheduleC IIIC drugsC haveC aC lesserCabuseC pot
entialC thanC IICandC anCacceptedC medicalC use.C ScheduleC IVC drugsChaveClowCabus
eCpotentialCandClimitedCdependenceCliability.
3.
WhenC involvedC inC phaseC IIIC drugC evaluationC studies,C whatC responsibiliti
esCwouldCtheCnurseChave?
A) WorkingCwithC animalsC whoC areC givenC experimentalC drugs
B) ChoosingC appropriateC patientsC toCbeC involvedC inC theC drugCstudy
C) MonitoringC andC observingCpatientsC closelyCforC adverseC effects
D) ConductingC researchC toC determineC effectivenessC ofC theC drug
ANSWER: C
Feedback:
PhaseC IIICstudiesCinvolveC useCofCaC drugCinC aCvastC clinicalC populationCinCwhichCp
atientsCareC askedC toC recordC anyCsymptomsC theyCexperienceC whileC takingC theC
drugs.CNursesCmayCbeCresponsibleCforChelpingCcollectCandCanalyzeCtheCinform
ationC toC beCsharedCwithCtheCFoodC andC DrugCAdministrationC (FDA)C butCwouldC
notC conductC researchC independentlyCbecauseC nursesC doC notC prescribeCmedi
cations.C UseC ofCanimalsC inCdrugCtestingCisC doneCinCtheC preclinicalC trials.CSelect
C patientsC whoC areC involvedC inC phaseC IIC studiesC toC participateC inC studiesCwher
eCtheC participantsC haveCtheC diseaseC theCdrugCisCintendedCtoCtreat.C TheseCpati
entsCareCmonitoredC closelyCforCdrugCactionC andC adverseC effects.C PhaseC ICstud
iesCinvolveChealthyChumanCvolunteersCwhoCareCusuallyCpaidCforC theirCparticip
ation.CNursesCmayCobserveCforCadverseCeffectsCandCtoxicity.
4.
WhatC conceptC isCconsideredC whenC genericC drugsC areC substitutedC forC b
randCnameCdrugs?
A) Bioavailability
B) CriticalC concentration
C) Distribution
D) Half-life
ANSWER: A
Feedback:
